-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gef1u2cXRArr++1GgPIYQEx9RQqGcOZbGP4dmuDyNgfTc7+Fvg+C4ztMn84A6WFh oHnG65ozXURWnBZp6pCCXg== 0001193805-09-001996.txt : 20091019 0001193805-09-001996.hdr.sgml : 20091019 20091019171138 ACCESSION NUMBER: 0001193805-09-001996 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20091019 DATE AS OF CHANGE: 20091019 GROUP MEMBERS: DEERFIELD CAPITAL, L.P. GROUP MEMBERS: DEERFIELD MANAGEMENT COMPANY, L.P. GROUP MEMBERS: DEERFIELD PRIVATE DESIGN FUND, L.P. GROUP MEMBERS: DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P. GROUP MEMBERS: DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED GROUP MEMBERS: DEERFIELD SPECIAL SITUATIONS FUND, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hana Biosciences Inc CENTRAL INDEX KEY: 0001140028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841588441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-79910 FILM NUMBER: 091126454 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6505886404 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EMAIL REAL ESTATE COM INC DATE OF NAME CHANGE: 20010504 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Flynn James E CENTRAL INDEX KEY: 0001352546 FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: 780 THIRD AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13D 1 e605953_13d-flynnhana.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ss. 24.13d-1(a) AND AMENDMENT THERETO FILED PURSUANT TO ss. 240.13D-2(a) HANA BIOSCIENCES, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.001 par value per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 40963P105 - -------------------------------------------------------------------------------- (CUSIP Number) James E. Flynn Deerfield Capital, L.P. 780 Third Avenue, 37th Floor New York, New York 10017 (212) 551-1600 With a copy to: Mark I. Fisher, Esq. Elliot Press, Esq. Katten Muchin Rosenman LLP 575 Madison Avenue New York, New York 10022 (212) 940-8800 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 8, 2009 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box |_|. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7 for other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of 18 Pages) SCHEDULE 13D CUSIP No. 40963P105 Page 2 of 18 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Deerfield Capital, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 15,356,157 Shares (1) WITH ------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER 0 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 15,356,157 Shares (1) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,356,157 Shares (1) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 19.83% (2) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- (1) Comprised of 14,057,212 shares of common stock and warrants to purchase 1,298,945 shares of common stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P. (2) Based on 76,145,146 outstanding shares of common stock of the Company as of October 8, 2009, as set forth in Exhibit 10.1 to the Company's current report on Form 8-K, filed with the Securities and Exchange Commission on October 8, 2009. SCHEDULE 13D CUSIP No. 40963P105 Page 3 of 18 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Deerfield Special Situations Fund, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS WC - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 2,009,974 Shares (3) WITH ------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER 0 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 2,009,974 Shares (3) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,009,974 Shares (3) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.64% (4) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- (3) Comprised of 1,924,316 shares of common stock and warrants to purchase 85,658 shares of common stock. (4) See footnote 2 above. SCHEDULE 13D CUSIP No. 40963P105 Page 4 of 18 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Deerfield Private Design Fund, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS WC - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 5,111,588 Shares (5) WITH ------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER 0 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 5,111,588 Shares (5) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,111,588 Shares (5) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.67% (6) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- (5) Comprised of 4,646,899 shares of common stock and warrants to purchase 464,689 shares of common stock. (6) See footnote 2 above. SCHEDULE 13D CUSIP No. 40963P105 Page 5 of 18 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Deerfield Private Design International, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS WC - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 8,234,595 Shares (7) WITH ------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER 0 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 8,234,595 Shares (7) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,234,595 Shares (7) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 10.71% (8) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- (7) Comprised of 7,485,997 shares of common stock and warrants to purchase 748,598 shares of common stock. (8) See footnote 2 above. SCHEDULE 13D CUSIP No. 40963P105 Page 6 of 18 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Deerfield Management Company, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 3,608,798 Shares (9) WITH ------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER 0 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 3,608,798 Shares (9) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,608,798 Shares (9) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.73% (10) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- (9) Comprised of 3,451,799 shares of common stock and warrants to purchase 156,999 shares of common stock held by Deerfield Special Situations Fund International Limited. (10) See footnote 2 above. SCHEDULE 13D CUSIP No. 40963P105 Page 7 of 18 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Deerfield Special Situations Fund International Limited - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS WC - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 3,608,798 Shares (11) WITH ------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER 0 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 3,608,798 Shares (11) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,608,798 Shares (11) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.73% (12) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON CO - -------------------------------------------------------------------------------- (11) Comprised of 3,451,799 shares of common stock and warrants to purchase 156,999 shares of common stock. (12) See footnote 2 above. SCHEDULE 13D CUSIP No. 40963P105 Page 8 of 18 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS James E. Flynn - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY ------------------------------------------------------------ EACH 8 SHARED VOTING POWER REPORTING PERSON 18,964,955 Shares (13) WITH ------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER 0 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 18,964,955 Shares (13) - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 18,964,955 Shares (13) - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 24.44% (14) - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - -------------------------------------------------------------------------------- (13) Comprised of 17,509,011 shares of common stock and warrants to purchase 1,455,944 shares of common stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P. and Deerfield Special Situations Fund International Limited. (14) See footnote 2 above. CUSIP No. 40963P105 Page 9 of 18 Pages This Schedule 13D is filed by (i) Deerfield Capital, L.P. ("Deerfield Capital"), (ii) Deerfield Special Situations Fund, L.P. ("Deerfield Special Situations Fund"), (iii) Deerfield Private Design Fund, L.P. ("Deerfield Private Design Fund"), (iv) Deerfield Private Design International, L.P. ("Deerfield Private Design International"), (v) Deerfield Management Company, L.P. ("Deerfield Management"), (vi) Deerfield Special Situations Fund International Limited ("Deerfield Special Situations International") and (vii) James E. Flynn, a natural person ("Flynn" and collectively with Deerfield Capital, Deerfield Special Situations Fund, Deerfield Private Design Fund, Deerfield Private Design International, Deerfield Management and Deerfield Special Situations International, the "Reporting Persons"), with respect to the securities of Hana Biosciences, Inc. Item 1. Security and Issuer This Statement on Schedule 13D relates to the common stock, par value $0.001 per share (the "Common Stock") of Hana Biosciences, Inc. (the "Company"), a Delaware corporation. The address of the Company's principal executive offices is 7000 Shoreline Court, Suite 370, South San Francisco, CA 94080. Item 2. Identity and Background (a) This Statement is filed as a joint statement pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act") by the Reporting Persons. (b) The address of the principal business and/or principal office of Deerfield Capital, Deerfield Special Situations Fund, Deerfield Private Design Fund, Deerfield Private Design International, Deerfield Management and Flynn is 780 Third Avenue, 37th Floor, New York, New York 10017. The address of the principal business and/or principal office of Deerfield Special Situations International is c/o Bisys Management, Bison Court, Columbus Centre, P.O. Box 3460, Road Town, Tortola, British Virgin Islands. (c) Flynn is the managing member of the general partner of each of Deerfield Capital and Deerfield Management. Deerfield Capital is the general partner of Deerfield Special Situations Fund, Deerfield Private Design Fund and Deerfield Private Design International, and Deerfield Management is the investment manager of Deerfield Special Situations International. Deerfield Special Situations Fund, Deerfield Private Design Fund, Deerfield Private Design International and Deerfield Special Situations International purchase, hold and sell securities and other investment products. Schedule A hereto sets forth information regarding persons referred in Instruction C to Schedule 13D. (d) During the last five years, none of the Reporting Persons, nor, to the best of each of the Reporting Person's knowledge, any of the persons listed on Schedule A attached hereto, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). CUSIP No. 40963P105 Page 10 of 18 Pages (e) During the last five years, none of the Reporting Persons, nor, to the best of each of the Reporting Person's knowledge, any of the persons listed on Schedule A attached hereto, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Deerfield Capital, Deerfield Special Situations Fund and Deerfield Private Design Fund are each organized under the laws of Delaware. Deerfield Management is organized under the laws of New York. Deerfield Private Design International and Deerfield Special Situations International are each organized under the laws of the British Virgin Islands. Flynn is a citizen of the United States of America. The Reporting Persons have entered into a Joint Filing Agreement, dated as of October 19, 2000, a copy of which is attached hereto as Exhibit 99.1. Item 3. Source and Amount of Funds or Other Consideration. Deerfield Special Situations Fund utilized available cash assets in the aggregate amount of approximately $2,352,764.47, as well as $227,793.03 of Warrant Redemption Price (as defined in Item 6 below), to acquire the 1,924,316 shares of Common Stock and warrants to purchase 85,658 shares of Common Stock reported herein as being held by it. Deerfield Private Design Fund utilized available cash assets in the aggregate amount of approximately $158,306.64, as well as $1,235,763.41 of Warrant Redemption Price, to acquire the 4,646,899 shares of Common Stock and warrants to purchase 464,689 shares of Common Stock reported herein as being held by it. Deerfield Private Design International utilized available cash assets in the aggregate amount of approximately $255,026.44, as well as $1,990,772.73 of Warrant Redemption Price, to acquire the 7,485,997 shares of Common Stock and warrants to purchase 748,598 shares of Common Stock reported herein as being held by it. Deerfield Special Situations Fund utilized available cash assets in the aggregate amount of approximately $4,179,164.98, as well as $417,514.60 of Warrant Redemption Price, to acquire the 3,451,799 shares of Common Stock and warrants to purchase 156,999 shares of Common Stock reported herein as being held by it. Cash funds for the purchase of the Common Stock and warrants to purchase Common Stock were derived from general working capital, and includes funds provided by investors in Deerfield Special Situations Fund, Deerfield Private Design Fund, Deerfield Private Design International and Deerfield Special Situations International, respectively. The Warrant Redemption Price was derived from the redemption of the Loan Warrants (as defined in Item 6 below), as further described in Item 6 below. Item 4. Purpose of Transaction. The Reporting Persons purchased the shares of Common Stock and the warrants to purchase shares of Common Stock solely for investment purposes. CUSIP No. 40963P105 Page 11 of 18 Pages Except as set forth herein, the Reporting Persons have no present plans or proposals that would result in or relate to any of the transactions or changes listed in Items 4(a) through 4(j) of Schedule 13D. Item 5. Interest in Securities of the Issuer. (a) (1) Reporting Persons Number of shares: 18,964,955 (15) Percentage of shares: 24.44% (16) (2) Deerfield Capital Number of shares: 15,356,157 (1) Percentage of shares: 19.83% (16) (3) Deerfield Special Situations Fund Number of shares: 2,009,974 (3) Percentage of shares: 2.64% (16) (4) Deerfield Private Design Fund Number of shares: 5,111,588 (5) Percentage of shares: 6.67% (16) (5) Deerfield Private Design International Number of shares: 8,234,595 (7) Percentage of shares: 10.71% (16) (6) Deerfield Management Number of shares: 3,608,798 (9) Percentage of shares: 4.73% (16) CUSIP No. 40963P105 Page 12 of 18 Pages (7) Deerfield Special Situations International Number of shares: 3,608,798 (11) Percentage of shares: 4.73% (16) (8) Flynn Number of shares: 18,964,955 (13) Percentage of shares: 24.44% (16) (b) (1) Deerfield Capital Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 15,356,157 shares (1) Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 15,356,157 shares (1) (2) Deerfield Special Situations Fund Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 2,009,974 shares (3) Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 2,009,974 shares (3) (3) Deerfield Private Design Fund Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 5,111,588 shares (5) Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 5,111,588 shares (5) (4) Deerfield Private Design International Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 8,234,595 shares (7) CUSIP No. 40963P105 Page 13 of 18 Pages Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 8,234,595 shares (7) (5) Deerfield Management Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 3,608,798 shares (9) Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 3,608,798 shares (9) (6) Deerfield Special Situations International Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 3,608,798 shares (11) Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 3,608,798 shares (11) (7) Flynn Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 18,964,955 shares (13) Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 18,964,955 shares (13) Flynn is the managing member of the general partner of each of Deerfield Capital and Deerfield Management. Deerfield Capital is the general partner of Deerfield Special Situations Fund, Deerfield Private Design Fund and Deerfield Private Design International. Deerfield Management is the investment manager of Deerfield Special Situations International. (15) Comprised of 17,509,011 shares of common stock and warrants to purchase 1,455,944 shares of common stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P. and Deerfield Special Situations Fund International Limited. (16) See footnote 2 above. CUSIP No. 40963P105 Page 14 of 18 Pages (c) The following table sets forth the transactions effected by the Reporting Persons in the shares of Common Stock of the Company during the 60 days prior to the date of filing of this Schedule 13D. All such transactions were purchases of shares of the Company's Common Stock and warrants to purchase shares of the Company's Common Stock in the Private Placement (as defined in Item 6 below).
- ---------------------------------------------------------------------------------------------------- Date Buyer Number of Shares of Common Price Stock Purchased - ---------------------------------------------------------------------------------------------------- October 8, 2009 Deerfield Special Situations 856,580 shares of Common $0.60 per unit (17) Fund Stock and warrants to purchase 85,658 shares of Common Stock - ---------------------------------------------------------------------------------------------------- October 8, 2009 Deerfield Private Design Fund 4,646,899 shares of Common $0.60 per unit (17) Stock and warrants to purchase shares 464,689 of Common Stock - ---------------------------------------------------------------------------------------------------- October 8, 2009 Deerfield Private Design 7,485,997 shares of Common $0.60 per unit (17) International Stock and warrants to purchase 748,598 shares of Common Stock - ---------------------------------------------------------------------------------------------------- October 8, 2009 Deerfield Special Situations 1,570,000 shares of Common $0.60 per unit (17) International Stock and warrants to purchase 156,999 shares of Common Stock - ----------------------------------------------------------------------------------------------------
(17) The per unit purchase price in the Private Placement (as defined in Item 6 below) was $0.60 per unit. Pursuant to the terms of the Private Placement, each unit was comprised of (i) one share of Common Stock and (ii) a seven-year warrant to purchase one-tenth of a share of Common Stock. (d) No other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock and warrants to purchase Common Stock held by the Reporting Persons. Item 6. Contracts, Arrangements, Understandings or Relationships with respect to Securities of the Issuer. Deerfield Special Situations Fund, Deerfield Special Situations International, Deerfield Private Design Fund and Deerfield Private Design International (collectively, the "Deerfield Funds") are each holders of Promissory Notes issued by the Company in the form attached as Exhibit 4.9 to the Company's Form 10-K for the year ended December 31, 2007 (the "Promissory Notes"), pursuant to CUSIP No. 40963P105 Page 15 of 18 Pages that certain Facility Agreement, dated October 30, 2007, by and among the Company and the Deerfield Funds, a copy of which is attached as Exhibit 10.24 to the Company's Form 10-K for the year ended December 31, 2007 (the "Facility Agreement"). The Deerfield Funds are also party to a Security Agreement, dated October 30, 2007, by and among the Company and the Deerfield Funds, a copy of which is attached as Exhibit 10.25 to the Company's Form 10-K for the year ended December 31, 2007 (the "Security Agreement"), which secures the Company's obligations to the Deerfield Funds under the Promissory Notes and Facility Agreement. On October 30, 2007, the Company issued to each Deerfield Fund Warrants to purchase Common Stock in the forms attached as Exhibit 4.1 and Exhibit 4.2 of the Company's Registration Statement on Form S-3 filed on November 19, 2007 (the "Loan Warrants"), which were issued by the Company in connection with transactions contemplated by the Facility Agreement. The terms of the Loan Warrants provided that upon the occurrence of certain events (including a delisting of the Common Stock, which occurred effective September 10, 2009), the Company would pay to the holder an amount equal to the Black Scholes value of the respective Loan Warrant (such amount, the "Warrant Redemption Price"). The Deerfield Funds entered into the letter agreement attached as Exhibit 10.1 to the Company's report on Form 8-K filed on September 10, 2009 (the "Letter Agreement"), pursuant to which in lieu of satisfying the Warrant Redemption Price in cash, the Company was permitted to satisfy such obligation, at the Deerfield Funds' election, upon the completion by the Company of a qualified financing on or prior to June 30, 2010 by the issuance to the Deerfield of the same type of securities that Deerfield would have received had the Warrant Redemption Price been invested in such financing. On October 8, 2009, the Company consummated a qualified financing (the "Private Placement") pursuant to a Securities Purchase Agreement, dated October 7, 2009 by and among the Company, the Deerfield Funds and the other investors party thereto, a copy of which is attached as Exhibit 10.1 to the Company's current report on Form 8-K filed on October 8, 2009 (the "Securities Purchase Agreement"). Pursuant to the terms of the Securities Purchase Agreement, the Deerfield Funds purchased an aggregate of 14,559,476 shares of Common Stock and warrants to purchase 1,455,944 shares of Common Stock in the form attached as Exhibit 4.2 to the Company's current report on Form 8-K filed on October 8, 2009 (the "New Warrants") in exchange for $496,000 in cash and application of the $3,871,843.77 of Warrant Redemption Price, and the Loan Warrants were cancelled. Item 7. Material to be Filed as Exhibits. Exhibit 99.1 Joint Filing Agreement dated as of October 19, 2009 by and among the Reporting Persons.* Exhibit 99.2 Power of Attorney.* Exhibit 99.3 Form of Promissory Note (incorporated by reference to Exhibit 4.9 of the Company's annual report on Form 10-K for the year ended December 31, 2007). Exhibit 99.4 Form of Series A Loan Warrant (incorporated by reference to Exhibit 4.1 of the Company's Registration Statement on Form S-3 filed on November 19, 2007. CUSIP No. 40963P105 Page 16 of 18 Pages Exhibit 99.5 Form of Series B Loan Warrant (incorporated by reference to Exhibit 4.2 of the Company's Registration Statement on Form S-3 filed on November 19, 2007. Exhibit 99.6 Form of New Warrant (incorporated by reference to Exhibit 4.2 of the Company's current report on Form 8-K filed on October 8, 2009). Exhibit 99.7 Facility Agreement (incorporated by reference to Exhibit 10.24 of the Company's annual report on Form 10-K for the year ended December 31, 2007). Exhibit 99.8 Security Agreement (incorporated by reference to Exhibit 10.25 of the Company's annual report on Form 10-K for the year ended December 31, 2007). Exhibit 99.9 Letter Agreement (incorporated by reference to Exhibit 10.1 of the Company's current report on Form 8-K filed on September 10, 2009). * Filed herewith. CUSIP No. 40963P105 Page 17 of 18 Pages SIGNATURE After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: October 19, 2009 DEERFIELD CAPITAL, L.P. By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD SPECIAL SITUATIONS FUND, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD PRIVATE DESIGN FUND, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory CUSIP No. 40963P105 Page 18 of 18 Pages DEERFIELD MANAGEMENT COMPANY, L.P. By: Flynn Management LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED By: Deerfield Management Company, L.P., Investment Manager By: Flynn Management LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory JAMES E. FLYNN /s/ Darren Levine ---------------------------------------------------- Darren Levine, Attorney-in-Fact CUSIP No. 40963P105 Schedule A General Partner of Deerfield Capital, L.P. The general partner of Deerfield Capital is J.E. Flynn Capital LLC. The address of the principal business and/or principal office of Deerfield Capital and J.E. Flynn Capital LLC is 780 Third Avenue, 37th Floor, New York, New York 10017. General Partner of Deerfield Special Situations Fund, L.P. The general partner of Deerfield Special Situations Fund is Deerfield Capital. The address of the principal business and/or principal office of Deerfield Capital and Deerfield Special Situations LP is 780 Third Avenue, 37th Floor, New York, New York 10017. General Partner of Deerfield Private Design Fund, L.P. The general partner of Deerfield Private Design Fund is Deerfield Capital. The address of the principal business and/or principal office of Deerfield Capital and Deerfield Special Situations LP is 780 Third Avenue, 37th Floor, New York, New York 10017. General Partner of Deerfield Private Design International, L.P. The general partner of Deerfield Private Design International is Deerfield Capital. The address of the principal business and/or principal office of Deerfield Capital and Deerfield Special Situations LP is 780 Third Avenue, 37th Floor, New York, New York 10017. General Partner of Deerfield Management Company, L.P. The general partner of Deerfield Management is Flynn Management LLC. The address of the principal business and/or principal office of Deerfield Management and Flynn Management LLC is 780 Third Avenue, 37th Floor, New York, New York 10017. Directors and Executive Officers of Deerfield Special Situations Fund International Limited The directors and officers of Deerfield Special Situations International are Peter Young, James E. Flynn and Graham Cook. Peter Young's and Graham Cook's principal business is as corporate directors. James E. Flynn is the managing member of the general partner of Deerfield Capital and Deerfield Management. The address of the principal business and/or principal office of Peter Young and Graham Cook is Deerfield Special Situations International, c/o Bisys Management, Bison Court, Columbus Centre, P.O. Box 3460, Road Town, Tortola, British Virgin Islands. The address of the principal business and/or principal office of James E. Flynn is 780 Third Avenue, 37th Floor, New York, New York 10017. EX-99.1 2 e605953_ex99-1.txt CUSIP No. 40963P105 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of Hana Biosciences, Inc. and that this Agreement be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument. IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 19th day of October, 2009. DEERFIELD CAPITAL, L.P. By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD SPECIAL SITUATIONS FUND, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD PRIVATE DESIGN FUND, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory CUSIP No. 40963P105 DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD MANAGEMENT COMPANY, L.P. By: Flynn Management LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED By: Deerfield Management Company, L.P., Investment Manager By: Flynn Management LLC, General Partner By: /s/ Darren Levine ---------------------------------------- Name: Darren Levine Title: Authorized Signatory JAMES E. FLYNN /s/ Darren Levine ---------------------------------------------------- Darren Levine, Attorney-in-Fact EX-99.2 3 e605953_ex99-2.txt CUSIP No. 40963P105 Exhibit 99.2 POWER OF ATTORNEY Know all by these presents, each of the undersigned hereby constitutes and appoints Darren Levine, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned (i) Forms 3, 4 and 5 (and all amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and the rules thereunder and (ii) reports on Schedule 13G and Schedule 13D (and all amendments thereto) in accordance with Section 13 of the Exchange Act and the rules thereunder, in each case with respect to the beneficial ownership of securities by the undersigned; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 4 or 5, Schedule 13G or Schedule 13D, complete and execute any amendment or amendments thereto, and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Section 13 or Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact. CUSIP No. 40963P105 IN WITNESS WHEREOF, each the undersigned has caused this Power of Attorney to be executed as of this 19th day of October, 2009. DEERFIELD CAPITAL, L.P. By: J.E. Flynn Capital LLC, General Partner By: /s/ James E. Flynn ----------------------------------- Name: James E. Flynn Title: Managing Member DEERFIELD SPECIAL SITUATIONS FUND, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ James E. Flynn ----------------------------------- Name: James E. Flynn Title: Managing Member DEERFIELD PRIVATE DESIGN FUND, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ James E. Flynn ----------------------------------- Name: James E. Flynn Title: Managing Member DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P. By: Deerfield Capital, L.P., General Partner By: J.E. Flynn Capital LLC, General Partner By: /s/ James E. Flynn ----------------------------------- Name: James E. Flynn Title: Managing Member DEERFIELD MANAGEMENT COMPANY, L.P. By: Flynn Management LLC, General Partner By: /s/ James E. Flynn ----------------------------------- Name: James E. Flynn Title: Managing Member DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED By: Deerfield Management Company, L.P., Investment Manager By: Flynn Management LLC, General Partner By: /s/ James E. Flynn ----------------------------------- Name: James E. Flynn Title: Managing Member JAMES E. FLYNN /s/ James E. Flynn - -------------------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----